Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...

As debates surrounding AI continue across industries, researchers at Cedars-Sinai Medical Center are using the technology to ...

Cascades Inc. ( CAS:CA) Q1 2026 Earnings Call May 7, 2026 9:00 AM EDT [Foreign Language] Good morning. My name is Julie, and I will be your conference operator today. At this time, I would like to ...

Roche has agreed to acquire PathAI, a Boston-based digital pathology firm, for up to $1.05 billion. Roche plans to pay $750 ...

A slippery droplet microarray enables parallel 3D bioprinting of separated, immersed hydrogel models, cutting array ...

PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...

QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...

Pathology education and diagnostics are being reshaped by digital slides, AI models, and multimodal analysis linking tissue images to molecular data. These innovations allow faster, more accessible, ...

Computational scattered light imaging shows the orientation and organization of tissue fibers at micrometer resolution. The colors represent different fiber orientations. Credit: Marios Georgiadis A ...